{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:45:45Z","timestamp":1790736345440,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky-2022-it23"],"award-info":[{"award-number":["lzujbky-2022-it23"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky-2021-it25"],"award-info":[{"award-number":["lzujbky-2021-it25"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["24JRRA411"],"award-info":[{"award-number":["24JRRA411"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["24JRRA312"],"award-info":[{"award-number":["24JRRA312"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271307"],"award-info":[{"award-number":["32271307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.biopha.2024.117389","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T04:29:52Z","timestamp":1725769792000},"page":"117389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Intrathecal administration of MCRT produced potent antinociception in chronic inflammatory pain models via \u03bc-\u03b4 heterodimer with limited side effects"],"prefix":"10.1016","volume":"179","author":[{"given":"Yaofeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingnian","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerine Peter","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-7797","authenticated-orcid":false,"given":"Shouliang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2024.117389_bib2","unstructured":"Global Pain Index Report 4th edition, 2020. \u3008https:\/\/www.gsk.com\/media\/6351\/2020-global-plain-index-report.pdf\u3009."},{"issue":"2","key":"10.1016\/j.biopha.2024.117389_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2024.117389_bib4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3390\/ph14111091","article-title":"Opioid analgesia and opioid-induced adverse effects: a review","volume":"14","author":"Paul","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.biopha.2024.117389_bib5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2024.117389_bib6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40263-019-00660-0","article-title":"Opioid-induced tolerance and hyperalgesia","volume":"33","author":"Mercadante","year":"2019","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2024.117389_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jcpt.12404","article-title":"Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?","volume":"41","author":"Albert-Vartanian","year":"2016","journal-title":"J. Clin. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib8","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1038\/s41467-022-31342-z","article-title":"Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects","volume":"13","author":"Tuhin","year":"2022","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.biopha.2024.117389_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000017118","article-title":"Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects","volume":"118","author":"Kandasamy","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"14","key":"10.1016\/j.biopha.2024.117389_bib10","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/bph.13823","article-title":"Allostery at opioid receptors: modulation with small molecule ligands","volume":"175","author":"Livingston","year":"2018","journal-title":"Br. J. Pharm."},{"issue":"392","key":"10.1016\/j.biopha.2024.117389_bib11","doi-asserted-by":"crossref","first-page":"eaal3447","DOI":"10.1126\/scitranslmed.aal3447","article-title":"Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief","volume":"9","author":"Jensen","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"46","key":"10.1016\/j.biopha.2024.117389_bib12","doi-asserted-by":"crossref","first-page":"12309","DOI":"10.1073\/pnas.1706656114","article-title":"Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission","volume":"114","author":"Yarwood","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"49","key":"10.1016\/j.biopha.2024.117389_bib13","doi-asserted-by":"crossref","first-page":"19778","DOI":"10.1073\/pnas.1115231108","article-title":"Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects","volume":"108","author":"Majumdar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2024.117389_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J. Pharm. Exp. Ther."},{"issue":"7619","key":"10.1016\/j.biopha.2024.117389_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"6328","key":"10.1016\/j.biopha.2024.117389_bib16","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.aai8636","article-title":"A nontoxic pain killer designed by modeling of pathological receptor conformations","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biopha.2024.117389_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med Chem."},{"issue":"21","key":"10.1016\/j.biopha.2024.117389_bib18","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2024.117389_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3389\/fphar.2020.01078","article-title":"Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2024.117389_bib20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/bph.15772","article-title":"Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities","volume":"180","author":"Gaborit","year":"2023","journal-title":"Br. J. Pharm."},{"issue":"15","key":"10.1016\/j.biopha.2024.117389_bib21","doi-asserted-by":"crossref","first-page":"10581","DOI":"10.1021\/acs.jmedchem.1c00683","article-title":"Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.117389_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.931573","article-title":"GPCR heteromers: An overview of their classification, function and physiological relevance","volume":"13","author":"Dale","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2024.117389_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into \u00b5-opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.biopha.2024.117389_bib24","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1021\/acs.jmedchem.0c00643","article-title":"Neuropeptide FF and its receptors: therapeutic applications and ligand development","volume":"63","author":"Nguyen","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1-3","key":"10.1016\/j.biopha.2024.117389_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.regpep.2012.08.008","article-title":"Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide","volume":"179","author":"Li","year":"2012","journal-title":"Regul. Pept."},{"issue":"9","key":"10.1016\/j.biopha.2024.117389_bib26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jphp.12761","article-title":"Supraspinal inhibitory effects of chimeric peptide MCRT on gastrointestinal motility in mice","volume":"69","author":"He","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117389_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/bcpt.13566","article-title":"MCRT, a multifunctional ligand of opioid and neuropeptide FF receptors, attenuates neuropathic pain in spared nerve injury model","volume":"128","author":"He","year":"2021","journal-title":"Basic Clin. Pharm. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117389_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/pm\/pnaa364","article-title":"Intrathecal drug delivery system: a pain management option for refractory cancer-related pain","volume":"22","author":"Wanderman","year":"2020","journal-title":"Pain. Med."},{"issue":"7","key":"10.1016\/j.biopha.2024.117389_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012285","article-title":"Intrathecal drug delivery systems for the management of chronic non-cancer pain: protocol for a systematic review of economic evaluations","volume":"6","author":"Duarte","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.biopha.2024.117389_bib30","series-title":"The National Academies Collection: Reports funded by National Institutes of Health","author":"Animals","year":"2011"},{"issue":"2","key":"10.1016\/j.biopha.2024.117389_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1073\/pnas.0502090103","article-title":"RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia","volume":"103","author":"Simonin","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.117389_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tetlet.2022.154239","article-title":"Gram-scale preparation of DAMGO by typical solid phase synthesis","volume":"112","author":"Chen","year":"2022","journal-title":"Tetrahedron Lett."},{"issue":"14","key":"10.1016\/j.biopha.2024.117389_bib33","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1021\/acs.jmedchem.8b00403","article-title":"Synthesis and evaluation of a novel bivalent selective antagonist for the Mu-delta opioid receptor heterodimer that reduces morphine withdrawal in mice","volume":"61","author":"Olson","year":"2018","journal-title":"J. Med Chem."},{"issue":"2","key":"10.1016\/j.biopha.2024.117389_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2024.117389_bib35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0169-409X(03)00101-7","article-title":"Spinal delivery of analgesics in experimental models of pain and analgesia","volume":"55","author":"Fairbanks","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117389_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173169","article-title":"Spinal administration of the multi-functional opioid\/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia","volume":"880","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117389_bib37","article-title":"In vitro opioid receptor assays","volume":"4","author":"Taylor","year":"2011","journal-title":"Curr. Protoc. Pharm. Chapter"},{"issue":"4","key":"10.1016\/j.biopha.2024.117389_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.117389_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/cns.12486","article-title":"Preclinical assessment of inflammatory pain","volume":"22","author":"Muley","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.biopha.2024.117389_bib41","doi-asserted-by":"crossref","first-page":"13791","DOI":"10.1038\/ncomms13791","article-title":"The Ca(2+)-activated chloride channel anoctamin-2 mediates spike-frequency adaptation and regulates sensory transmission in thalamocortical neurons","volume":"7","author":"Ha","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2024.117389_bib42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ajpath.2018.12.009","article-title":"Spexin\/NPQ Induces FBJ osteosarcoma oncogene (Fos) and produces antinociceptive effect against inflammatory pain in the mouse model","volume":"189","author":"Lv","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.biopha.2024.117389_bib44","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/bph.13489","article-title":"BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice","volume":"173","author":"Li","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.biopha.2024.117389_bib45","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1021\/acs.jmedchem.1c00694","article-title":"Development of multifunctional and orally active cyclic peptide agonists of opioid\/neuropeptide ff receptors that produce potent, long-lasting, and peripherally restricted antinociception with diminished side effects","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med Chem."},{"issue":"9","key":"10.1016\/j.biopha.2024.117389_bib46","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1523\/JNEUROSCI.22-09-03663.2002","article-title":"Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal","volume":"22","author":"Shaw-Lutchman","year":"2002","journal-title":"J. Neurosci."},{"issue":"23","key":"10.1016\/j.biopha.2024.117389_bib47","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.2232594100","article-title":"Essential role for RGS9 in opiate action","volume":"100","author":"Zachariou","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.117389_bib48","doi-asserted-by":"crossref","first-page":"112043","DOI":"10.1016\/j.bbr.2019.112043","article-title":"The influence of a new derivate of kisspeptin-10-Kissorphin (KSO) on the rewarding effects of morphine in the conditioned place preference (CPP) test in male rats","volume":"372","author":"Gibula-Tarlowska","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"3-4","key":"10.1016\/j.biopha.2024.117389_bib49","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jpain.2019.08.016","article-title":"Spinal DN-9, a peptidic multifunctional opioid\/neuropeptide FF agonist produced potent nontolerance forming analgesia with limited side effects","volume":"21","author":"Wang","year":"2019","journal-title":"J. Pain."},{"key":"10.1016\/j.biopha.2024.117389_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.667511","article-title":"Behavioral assessment of sensory, motor, emotion, and cognition in rodent models of intracerebral hemorrhage","volume":"12","author":"Shi","year":"2021","journal-title":"Front Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117389_bib51","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/j.pain.0000000000001768","article-title":"Activation of \u00b5-\u03b4 opioid receptor heteromers inhibits neuropathic pain behavior in rodents","volume":"161","author":"Tiwari","year":"2020","journal-title":"Pain"},{"issue":"131","key":"10.1016\/j.biopha.2024.117389_bib52","doi-asserted-by":"crossref","first-page":"ra54","DOI":"10.1126\/scisignal.2000807","article-title":"Increased abundance of opioid receptor heteromers after chronic morphine administration","volume":"3","author":"Gupta","year":"2010","journal-title":"Sci. Signal"},{"issue":"22","key":"10.1016\/j.biopha.2024.117389_bib53","doi-asserted-by":"crossref","first-page":"13618","DOI":"10.1021\/acs.jmedchem.0c00901","article-title":"Synthesis and pharmacology of a novel mu-delta opioid receptor heteromer-selective agonist based on the carfentanyl template","volume":"63","author":"Faouzi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.117389_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fphar.2015.00205","article-title":"Multi-target pharmacology: possibilities and limitations of the \"skeleton key approach\" from a medicinal chemist perspective","volume":"6","author":"Talevi","year":"2015","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.117389_bib55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bph.12663","article-title":"Heteromers of \u03bc-\u03b4 opioid receptors: new pharmacology and novel therapeutic possibilities","volume":"172","author":"Fujita","year":"2015","journal-title":"Br. J. Pharm."},{"issue":"18","key":"10.1016\/j.biopha.2024.117389_bib56","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1021\/acs.biochem.0c00498","article-title":"FBNTI, a DOR-selective antagonist that allosterically activates MOR within a MOR-DOR heteromer","volume":"60","author":"Akg\u00fcn","year":"2020","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.biopha.2024.117389_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/syn.10305","article-title":"Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: a comparative autoradiographic study","volume":"51","author":"Gouard\u00e8res","year":"2004","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.biopha.2024.117389_bib58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0306-4522(02)00419-0","article-title":"Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands","volume":"115","author":"Gouard\u00e8res","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2024.117389_bib59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2017.02.003","article-title":"Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice","volume":"291","author":"Lin","year":"2017","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bph.14848","article-title":"The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via mu- and kappa-opioid receptors","volume":"177","author":"Xu","year":"2019","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2024.117389_bib61","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1124\/jpet.109.156711","article-title":"Nociceptin\/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin\/orphanin FQ\/mu-opioid receptor agonists","volume":"331","author":"Khroyan","year":"2009","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0306-4522(02)00931-4","article-title":"Activation of spinal neuropeptide FF and the neuropeptide FF receptor 2 during inflammatory hyperalgesia in rats","volume":"118","author":"Yang","year":"2003","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib63","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2004.02.001","article-title":"Pain- and morphine-associated transcriptional regulation of neuropeptide FF and the G-protein-coupled NPFF2 receptor gene","volume":"16","author":"Nystedt","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2024.117389_bib64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0196-9781(99)00100-X","article-title":"Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models","volume":"20","author":"Xu","year":"1999","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.biopha.2024.117389_bib65","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1074\/jbc.M606946200","article-title":"Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity","volume":"282","author":"Roumy","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.biopha.2024.117389_bib66","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.1222044110","article-title":"Identification of a \u03bc-\u03b4 opioid receptor heteromer-biased agonist with antinociceptive activity","volume":"110","author":"Gomes","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1-2","key":"10.1016\/j.biopha.2024.117389_bib67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpain.2019.05.017","article-title":"A novel mu-delta opioid agonist demonstrates enhanced efficacy with reduced tolerance and dependence in mouse neuropathic pain models","volume":"21","author":"Lei","year":"2020","journal-title":"J. Pain."},{"issue":"52","key":"10.1016\/j.biopha.2024.117389_bib68","doi-asserted-by":"crossref","first-page":"19208","DOI":"10.1073\/pnas.0506627102","article-title":"Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series","volume":"102","author":"Daniels","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuron.2018.03.002","article-title":"Functional divergence of delta and Mu opioid receptor organization in CNS pain circuits","volume":"98","author":"Wang","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2024.117389_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108701","article-title":"Peripheral antinociceptive effects of a bifunctional \u03bc and \u03b4 opioid receptor ligand in rat model of inflammatory bladder pain","volume":"196","author":"Terashvili","year":"2021","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2024.117389_bib71","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.peptides.2005.07.023","article-title":"A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl\/6J mice","volume":"27","author":"Marchand","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2024.117389_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2013.03.046","article-title":"Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice","volume":"248","author":"Han","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.117389_bib73","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.peptides.2005.09.018","article-title":"Rat NPFF(1) receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide","volume":"27","author":"Chen","year":"2006","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.biopha.2024.117389_bib74","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/bph.13489","article-title":"BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice","volume":"173","author":"Li","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117389_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2014.10.018","article-title":"Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions","volume":"584","author":"Malin","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.biopha.2024.117389_bib76","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/j.pain.0000000000001262","article-title":"A bifunctional-biased mu-opioid agonist-neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects","volume":"159","author":"Drieu la Rochelle","year":"2018","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.biopha.2024.117389_bib77","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1523\/JNEUROSCI.20-12-04555.2000","article-title":"Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain","volume":"20","author":"Sim-Selley","year":"2000","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib78","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u03bc-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharm. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.117389_bib79","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/j.pain.0000000000002320","article-title":"Antagonism of the mu-delta opioid receptor heterodimer enhances opioid antinociception by activating Src and calcium\/calmodulin-dependent protein kinase II signaling","volume":"163","author":"Keresztes","year":"2022","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.biopha.2024.117389_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058362","article-title":"Anti-analgesic effect of the mu\/delta opioid receptor heteromer revealed by ligand-biased antagonism","volume":"8","author":"Milan-Lobo","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.biopha.2024.117389_bib81","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.3390\/ijms221910290","article-title":"Opioid addiction and opioid receptor dimerization: structural modeling of the OPRD1 and OPRM1 heterodimer and its signaling pathways","volume":"22","author":"Wu","year":"2021","journal-title":"Int J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224012745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224012745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:23:18Z","timestamp":1784762598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224012745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":81,"alternative-id":["S0753332224012745"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117389","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal administration of MCRT produced potent antinociception in chronic inflammatory pain models via \u03bc-\u03b4 heterodimer with limited side effects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117389"}}